These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1636838)

  • 21. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
    Hippisley-Cox J; Coupland C
    BMJ; 2016 Jul; 354():i3477. PubMed ID: 27413012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study.
    Bruce DG; Davis WA; Starkstein SE; Davis TM
    Diabetologia; 2005 Dec; 48(12):2532-9. PubMed ID: 16292463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study.
    Gamble JM; Chibrikov E; Twells LK; Midodzi WK; Young SW; MacDonald D; Majumdar SR
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):43-52. PubMed ID: 27865756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes, myocardial infarction and stroke are distinct and duration-dependent predictors of subsequent cardiovascular events and all-cause mortality in older men.
    Yeap BB; McCaul KA; Flicker L; Hankey GJ; Almeida OP; Golledge J; Norman PE
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1038-47. PubMed ID: 25548977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo-Perin P;
    Diabetologia; 2005 Mar; 48(3):427-34. PubMed ID: 15696295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study.
    Lee AJ; Wang JJ; Kifley A; Mitchell P
    Ophthalmology; 2006 Jul; 113(7):1069-76. PubMed ID: 16815396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes.
    Tanasescu M; Leitzmann MF; Rimm EB; Hu FB
    Circulation; 2003 May; 107(19):2435-9. PubMed ID: 12719277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-reported diabetes and mortality in a prospective Chinese elderly cohort study in Hong Kong.
    Shen C; Schooling CM; Chan WM; Lee SY; Leung GM; Lam TH
    Prev Med; 2014 Jul; 64():20-6. PubMed ID: 24704132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients.
    Zoppini G; Targher G; Chonchol M; Negri C; Stoico V; Pichiri I; Lippi G; Muggeo M; Bonora E
    Atherosclerosis; 2010 Jun; 210(2):575-80. PubMed ID: 20031129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between serum 25(OH)D
    Samefors M; Scragg R; Länne T; Nyström FH; Östgren CJ
    Diabet Med; 2017 Mar; 34(3):372-379. PubMed ID: 27862247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46).
    Riphagen IJ; Logtenberg SJ; Groenier KH; van Hateren KJ; Landman GW; Struck J; Navis G; Kootstra-Ros JE; Kema IP; Bilo HJ; Kleefstra N; Bakker SJ
    Atherosclerosis; 2015 Sep; 242(1):179-85. PubMed ID: 26201002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies.
    Evans JM; Wang J; Morris AD
    BMJ; 2002 Apr; 324(7343):939-42. PubMed ID: 11964337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes.
    Rossi A; Zoppini G; Benfari G; Geremia G; Bonapace S; Bonora E; Vassanelli C; Enriquez-Sarano M; Targher G
    Am J Med; 2017 Jan; 130(1):70-76.e1. PubMed ID: 27555095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studies.
    Olafsdottir E; Aspelund T; Sigurdsson G; Benediktsson R; Thorsson B; Harris TB; Launer LJ; Eiriksdottir G; Gudnason V
    BMC Public Health; 2013 Jan; 13():36. PubMed ID: 23320535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resting heart rate and measures of effort-related cardiac autonomic dysfunction predict cardiovascular events in asymptomatic type 2 diabetes.
    Zafrir B; Azencot M; Dobrecky-Mery I; Lewis BS; Flugelman MY; Halon DA
    Eur J Prev Cardiol; 2016 Aug; 23(12):1298-306. PubMed ID: 26701872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of type 2 diabetes strongly predicts all-cause and cardiovascular mortality in people referred for coronary angiography.
    Silbernagel G; Rosinger S; Grammer TB; Kleber ME; Winkelmann BR; Boehm BO; März W
    Atherosclerosis; 2012 Apr; 221(2):551-7. PubMed ID: 22305263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997-2011.
    Huo L; Magliano DJ; Rancière F; Harding JL; Nanayakkara N; Shaw JE; Carstensen B
    Diabetologia; 2018 May; 61(5):1055-1063. PubMed ID: 29473119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up.
    Svendstrup M; Christiansen MS; Magid E; Hommel E; Feldt-Rasmussen B
    J Diabetes Complications; 2013; 27(6):570-5. PubMed ID: 23932410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minority underrepresentation in cardiovascular outcome trials for type 2 diabetes.
    Hoppe C; Kerr D
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):13. PubMed ID: 28010783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.